(Adds adjusted profit, background in paragraphs 3-7) COPENHAGEN, Aug 4 (Reuters) – Novo Nordisk, the maker of weight-loss drug Wegovy, reported a second-quarter adjusted operating profit above
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Volvo Cars appoints Klaus Zellmer as CEO
Sept 20 (Reuters) - Volvo Cars has appointed Klaus Zellmer as President and Chief Executive…
Washington DC [US], September 20 (ANI): Christopher McDonald has revealed that he was originally approached…
Iran informed that US plans to resume action, state media reports
DUBAI, Sept 20 (Reuters) - Iran received information that the United States, with the backing…
